Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Pediatr Res ; 88(1): 27-37, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32120374

RESUMO

BACKGROUND: Mechanical ventilation of preterm neonates is associated with neuroinflammation and an increased risk of adverse neurological outcomes. Human amnion epithelial cells (hAECs) have anti-inflammatory and regenerative properties. We aimed to determine if intravenous administration of hAECs to preterm lambs would reduce neuroinflammation and injury at 2 days of age. METHODS: Preterm lambs were delivered by cesarean section at 128-130 days' gestation (term is ~147 days) and either ventilated for 48 h or humanely killed at birth. Lambs received 3 mL surfactant (Curosurf) via endotracheal tube prior to delivery (either with or without 90 × 106 hAECs) and 3 mL intravenous phosphate-buffered saline (with or without 90 × 106 hAECs, consistent with intratracheal treatment) after birth. RESULTS: Ventilation increased microglial activation, total oligodendrocyte cell number, cell proliferation and blood-brain barrier permeability (P < 0.05, PBS + ventilation and hAEC + ventilation vs. control), but did not affect numbers of immature and mature oligodendrocytes. Ventilation reduced astrocyte and neuron survival (P < 0.05, PBS + ventilation and hAEC + ventilation vs. control). hAEC administration did not alter markers of neuroinflammation or injury within the white or gray matter. CONCLUSIONS: Mechanical ventilation for 48 h upregulated markers of neuroinflammation and injury in preterm lambs. Administration of hAECs did not affect markers of neuroinflammation or injury. IMPACT: Mechanical ventilation of preterm lambs for 48 h, in a manner consistent with contemporary neonatal intensive care, causes neuroinflammation, neuronal loss and pathological changes in oligodendrocyte and astrocyte survival consistent with evolving neonatal brain injury.Intravenous administration of hAECs immediately after birth did not affect neonatal cardiorespiratory function and markers of neuroinflammation or injury.Reassuringly, our findings in a translational large animal model demonstrate that intravenous hAEC administration to the preterm neonate is safe.Considering that hAECs are being used in phase 1 trials for the treatment of BPD in preterm infants, with future trials planned for neonatal neuroprotection, we believe these observations are highly relevant.


Assuntos
Âmnio/metabolismo , Encéfalo/patologia , Transplante de Células/métodos , Células Epiteliais/metabolismo , Inflamação , Animais , Animais Recém-Nascidos , Barreira Hematoencefálica , Proliferação de Células , Feminino , Substância Cinzenta/patologia , Humanos , Infusões Intravenosas , Masculino , Microglia/metabolismo , Oligodendroglia/metabolismo , Permeabilidade , Regeneração , Respiração Artificial , Ovinos , Substância Branca/patologia
2.
Pediatr Res ; 75(2): 281-7, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24232635

RESUMO

BACKGROUND: Antenatal inflammation and maternal corticosteroids induce fetal lung maturation but interfere with late lung development. Canonical Wingless-Int (Wnt) signaling directs lung development and repair. We showed that intra-amniotic (IA) lipopolysaccharide (LPS) exposure disrupted developmental signaling pathways in the preterm lamb lungs. Therefore, we hypothesized that pulmonary Wnt signaling was altered by exposure to IA LPS and/or antenatal corticosteroids. METHODS: Ovine fetuses were exposed to IA LPS, maternal intramuscular betamethasone, a control saline injection, or a combination thereof at 107 and/or 114 d gestational age (term = 150 d gestational age) before delivery at 121 d gestational age. RESULTS: IA LPS exposure decreased the lung expression of lymphoid enhancer-binding factor 1 (LEF1), a major Wnt pathway effector. WNT1, WNT4, and downstream messenger ß-catenin decreased after LPS exposure. WNT7b mRNA increased fourfold 14 d post-LPS exposure. Betamethasone treatment 7 d before LPS exposure prevented the reduction in LEF1 expression, whereas betamethasone administration after LPS normalized the LPS-induced increase in Wnt7b mRNA. CONCLUSION: IA LPS exposure decreased canonical Wnt signaling in the developing lung. Antenatal corticosteroids before or after IA inflammation had different effects on pulmonary Wnt signaling. This study provides new insights into possible mechanisms by which prenatal inflammation affects lung development and how corticosteroid can be beneficial in this setting.


Assuntos
Betametasona/administração & dosagem , Lipopolissacarídeos/administração & dosagem , Pulmão/patologia , Via de Sinalização Wnt , Animais , Betametasona/química , Feminino , Quinase 3 da Glicogênio Sintase/metabolismo , Glicogênio Sintase Quinase 3 beta , Inflamação , Lipopolissacarídeos/química , Pulmão/metabolismo , Fator 1 de Ligação ao Facilitador Linfoide/metabolismo , Exposição Materna , Fosforilação , Gravidez , Prenhez , Ovinos , Carneiro Doméstico , Fatores de Tempo , Proteínas Wnt/metabolismo , beta Catenina/metabolismo
3.
Am J Physiol Lung Cell Mol Physiol ; 303(9): L778-87, 2012 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-22962010

RESUMO

Chorioamnionitis and antenatal corticosteroids mature the fetal lung functionally but disrupt late-gestation lung development. Because Sonic Hedgehog (Shh) signaling is a major pathway directing lung development, we hypothesized that chorioamnionitis and antenatal corticosteroids modulated Shh signaling, resulting in an altered fetal lung structure. Time-mated ewes with singleton ovine fetuses received an intra-amniotic injection of lipopolysaccharide (LPS) and/or maternal intramuscular betamethasone 7 and/or 14 days before delivery at 120 days gestational age (GA) (term = 150 days GA). Intra-amniotic LPS exposure decreased Shh mRNA levels and Gli1 protein expression, which was counteracted by both betamethasone pre- or posttreatment. mRNA and protein levels of fibroblast growth factor 10 and bone morphogenetic protein 4, which are important mediators of lung development, increased 2-fold and 3.5-fold, respectively, 14 days after LPS exposure. Both 7-day and 14-day exposure to LPS changed the mRNA levels of elastin (ELN) and collagen type I alpha 1 (Col1A1) and 2 (Col1A2), which resulted in fewer elastin foci and increased collagen type I deposition in the alveolar septa. Corticosteroid posttreatment prevented the decrease in ELN mRNA and increased elastin foci and decreased collagen type I deposition in the fetal lung. In conclusion, fetal lung exposure to LPS was accompanied by changes in key modulators of lung development resulting in abnormal lung structure. Betamethasone treatment partially prevented the changes in developmental processes and lung structure. This study provides new insights into clinically relevant prenatal exposures and fetal lung development.


Assuntos
Betametasona/farmacologia , Corioamnionite/metabolismo , Feto/metabolismo , Glucocorticoides/farmacologia , Proteínas Hedgehog/metabolismo , Lipopolissacarídeos/farmacologia , Alvéolos Pulmonares/metabolismo , Animais , Betametasona/uso terapêutico , Proteína Morfogenética Óssea 4/genética , Proteína Morfogenética Óssea 4/metabolismo , Proliferação de Células , Corioamnionite/tratamento farmacológico , Corioamnionite/imunologia , Colágeno Tipo I/metabolismo , Elastina/metabolismo , Feminino , Feto/efeitos dos fármacos , Feto/embriologia , Feto/patologia , Fator 10 de Crescimento de Fibroblastos/genética , Fator 10 de Crescimento de Fibroblastos/metabolismo , Expressão Gênica , Regulação da Expressão Gênica no Desenvolvimento , Glucocorticoides/uso terapêutico , Proteínas de Choque Térmico HSP70/metabolismo , Proteínas Oncogênicas/genética , Proteínas Oncogênicas/metabolismo , Gravidez , Alvéolos Pulmonares/efeitos dos fármacos , Alvéolos Pulmonares/embriologia , Alvéolos Pulmonares/patologia , Ovinos , Transdução de Sinais , Transativadores/genética , Transativadores/metabolismo , Proteína GLI1 em Dedos de Zinco
4.
Clin Perinatol ; 39(3): 483-96, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22954264

RESUMO

Various commercial and home-made continuous positive airway pressure (CPAP) systems are described in this article. CPAP may be delivered via a range of device-patient interfaces; nasal CPAP is most common, and short binasal prongs impose the least extrinsic load impedance on the infant. The source of pressure generation is categorized as either constant pressure or constant flow. The efficacy of different systems may vary according to whether lung volume recruitment, airway patency, minimization of work of breathing, or central nervous system stimulation are the primary goal of the clinical decision to use CPAP therapy.


Assuntos
Pressão Positiva Contínua nas Vias Aéreas/métodos , Recém-Nascido Prematuro , Síndrome do Desconforto Respiratório do Recém-Nascido/terapia , Pressão Positiva Contínua nas Vias Aéreas/efeitos adversos , Pressão Positiva Contínua nas Vias Aéreas/instrumentação , Humanos , Recém-Nascido , Medidas de Volume Pulmonar , Síndrome do Desconforto Respiratório do Recém-Nascido/fisiopatologia , Trabalho Respiratório/fisiologia
5.
Semin Fetal Neonatal Med ; 17(2): 92-8, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22277109

RESUMO

Epidemiological studies demonstrate that in-utero growth restriction and low birth weight are associated with impaired lung function and increased respiratory morbidity from infancy, throughout childhood and into adulthood. Chronic restriction of nutrients and/or oxygen during late pregnancy causes abnormalities in the airways and lungs of offspring, including smaller numbers of enlarged alveoli with thicker septal walls and basement membranes. The structural abnormalities and impaired lung function seen soon after birth persist or even progress with age. These changes are likely to cause lung symptomology through life and hasten lung aging.


Assuntos
Retardo do Crescimento Fetal/epidemiologia , Recém-Nascido de Baixo Peso , Doenças do Prematuro/epidemiologia , Pneumopatias/epidemiologia , Alvéolos Pulmonares/embriologia , Estatura , Doença Crônica , Feminino , Retardo do Crescimento Fetal/fisiopatologia , Idade Gestacional , Humanos , Incidência , Recém-Nascido , Recém-Nascido Prematuro , Doenças do Prematuro/fisiopatologia , Tamanho do Órgão , Gravidez , Alvéolos Pulmonares/crescimento & desenvolvimento , Troca Gasosa Pulmonar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA